IDXX Financial Overview

Comprehensive financial analysis and stock performance data for IDXX. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

IDXX

IDEXX Laboratories, Inc.

Healthcare

CEO: Mr. Jonathan J. Mazelsky

IPO: 1991-06-21

11,000 employees

$429.03

-8.20 (-1.91%)

Market Cap

34.89B

Enterprise Value

35B

Revenue (TTM)

3.9B

Net Income

887.9M

P/E Ratio

39.77x

ROE

55.82%

Valuation Metrics

Market Cap

35B

Enterprise Value

35B

P/E Ratio

39.77x

P/S Ratio

8.95x

P/B Ratio

22.13x

EV/Sales

8.92x

EV/FCF

43.57x

Earnings Yield

2.51%

FCF Yield

2.29%

Price to Operating Cash Flow

38.01x

Gross Margin

61.08%

Margin Metrics

Operating Margin

28.99%

Net Margin

22.78%

Pretax Margin

28.48%

ROIC

37.77%

Dividends

Payout Ratio

0.00%

Dividend Yield

0.00%

Dividend per Share

$0.00

Return Metrics

ROE

55.82%

ROCE

50.78%

ROA

26.96%

PEG Ratio

14.36x

Payout Ratio

0.00%

Financial Health

Debt to Assets

5.09%

Net Debt/EBITDA

-0.09x

Growth Metrics

3Y Revenue Growth

7.86%

5Y Revenue Growth

11.12%

10Y Revenue Growth

12.30%

3Y Net Income Growth

7.26%

5Y Net Income Growth

16.78%

10Y Net Income Growth

19.49%

3Y OCF Growth

8.37%

5Y OCF Growth

16.18%

10Y OCF Growth

16.96%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

IDXX

IDXX·Total: -23.83%·CAGR: -23.83%